Generic Name and Formulations:
Levothyroxine sodium 25mcg, 50mcg (dye-free), 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 150mcg, 175mcg, 200mcg, 300mcg; scored tabs.
Gemini Laboratories, LLC
Indications for UNITHROID:
Take in AM on empty stomach. Hypothyroidism: 1.7mcg/kg once daily. >50yrs, or <50yrs with cardiovascular disease: initially 25–50mcg once daily; titrate in increments of 12.5–25mcg every 4–6 weeks. Elderly with cardiovascular disease: initially 12.5–25mcg once daily; titrate in increments of 12.5–25mcg every 4–6 weeks. Usual max 200mcg/day. Severe hypothyroidism: initially 12.5–25mcg once daily; titrate in increments of 25mcg/day every 4 weeks. Subclinical hypothyroidism, secondary or tertiary hypothyroidism: see literature.
Give once daily on empty stomach. May crush tabs and mix in 5–10mL water. Hypothyroidism: 0–3months: 10–15mcg/kg per day; 3–6months: 8–10mcg/kg per day; 6–12months: 6–8mcg/kg per day; 1–5yrs: 5–6mcg/kg per day; 6–12yrs: 4–5mcg/kg per day; >12yrs: 2–3mcg/kg per day; growth and puberty complete: as adult. Chronic or severe hypothyroidism: initially 25mcg/day; titrate in increments of 25mcg every 4weeks. Infants with serum T4<5mcg/dL: initially 50mcg/day.
Uncorrected adrenal insufficiency. Untreated thyrotoxicosis. Acute MI.
Not for treatment of obesity for weight loss.
Ineffective for weight reduction in euthyroid patients. Not for treatment of infertility. Cardiovascular disease. Seizures. Adrenocortical insufficiency. Increased sensitivity in severe hypothyroidism. Autonomous thyroid tissue. Myxedema coma: use IV levothyroxine. Elderly. Pregnancy (Cat.A); do not discontinue due to pregnancy. Nursing mothers.
See full labeling. Absorption reduced by some foods (eg, soy, fiber), aluminum and magnesium hydroxide, simethicone, calcium carbonate, sodium polystyrene sulfonate, bile acid sequestrants, iron, sucralfate (give at least 4hrs apart). Potentiates, and is potentiated by, tri- and tetracyclic antidepressants, sympathomimetics. Antagonized by hepatic enzyme inducers (eg, carbamazepine, phenytoin, phenobarbital, rifampin), sertraline. Antagonizes digoxin. Marked hypertension and tachycardia with ketamine. Estrogens affect thyroid function tests. Monitor oral anticoagulants, antidiabetic agents, theophylline.
Hyperthyroidism, decreased bone mineral density, transient alopecia; seizures (rare); pseudotumor cerebri in children.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Tools to Address the Opioid Crisis
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Nonsinogenic Headache vs Chronic Rhinosinusitis Differential Diagnosis Based on SNOT-22 Patterns
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Factors Promoting Participation in Self-Management Training Program for Chronic Pain
- Gendered Perceptions of Socially Acceptable Pain Relief Strategies
- Majority of Internists Still Have Financial Ties to Industry